Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Clinical Pharmacology|April 18, 2001
Use of in vitro drug metabolism data to evaluate metabolic drug-drug interactions in man: the need for quantitative databasesA D Rodrigues, G A Winchell, M R DobrinskaJournal of Clinical Pharmacology|October 1, 1993
Finasteride, a steroid 5 alpha-reductase inhibitor, does not affect the oxidative metabolism of antipyrineG A Winchell, S Gregoire, A M Taylor, et al.Pharmaceutical Research|November 8, 2001
An extended point-area deconvolution approach for assessing drug input ratesK C Yeh, D J Holder, G A Winchell, et al.Antimicrobial Agents and Chemotherapy|September 15, 2001
Pharmacokinetic profile and tolerability of indinavir-ritonavir combinations in healthy volunteersA J Saah, G A Winchell, M L Nessly, et al.European Journal of Clinical Pharmacology|January 1, 1994
Plasma concentrations and effect on testosterone metabolism after single doses of MK-0434, a steroid 5 alpha-reductase inhibitor, in healthy subjectsA Van Hecken, M Depré, J I Schwartz, et al.Clinical Pharmacology and Therapeutics|May 9, 2000
The steady-state disposition of indinavir is not altered by the concomitant administration of clarithromycinS E Boruchoff, M G Sturgill, K W Grasing, et al.Antimicrobial Agents and Chemotherapy|April 24, 2004
Pharmacokinetics of indinavir combined with low-dose ritonavir in human immunodeficiency virus type 1-infected childrenA S Bergshoeff, P L A Fraaij, A M C van Rossum, et al.The Journal of Clinical Endocrinology and Metabolism|August 1, 1996
Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in menJ I Schwartz, A Van Hecken, P J De Schepper, et al.Pageof 1